Intravenous-to-Oral Antibiotics Transition in Healthcare-Associated Pneumonia Safe
De-escalating antibiotic regimens from intravenous to oral is safe in clinically stable patients with healthcare-associated pneumonia.
De-escalating antibiotic regimens from intravenous to oral is safe in clinically stable patients with healthcare-associated pneumonia.
An NS5A mutation renders hepatitis C virus resistant to NS5A inhibitors but susceptible to protease inhibitors.
HBV promotes HCC carcinogenesis by integrating viral DNA into the host genome.
Incentive payments to primary care physicians for providing comprehensive care to medically complex patients did not improve quality of care.